购物车
- 全部删除
- 您的购物车当前为空
NM107 (2'-C-Methylcytidine) 是一种具有广谱抗病毒活性的核糖核苷,是丙型肝炎病毒 NS5B 聚合酶的核苷抑制剂,在野生型复制子细胞中的 EC50 为 1.85 μM。
为众多的药物研发团队赋能,
让新药发现更简单!
NM107 (2'-C-Methylcytidine) 是一种具有广谱抗病毒活性的核糖核苷,是丙型肝炎病毒 NS5B 聚合酶的核苷抑制剂,在野生型复制子细胞中的 EC50 为 1.85 μM。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
2 mg | ¥ 297 | 现货 | |
5 mg | ¥ 481 | 现货 | |
10 mg | ¥ 726 | 现货 | |
25 mg | ¥ 1,080 | 现货 | |
50 mg | ¥ 1,280 | 现货 | |
100 mg | ¥ 2,090 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 496 | 现货 |
产品描述 | NM107 (2'-C-Methylcytidine) is a ribonucleoside with broad-spectrum antiviral activity, is an nucleoside inhibitor of the hepatitis C virus (HCV) NS5B polymerase, NM 107 in the wild-type replicon cells with the EC50 of 1.85 μM |
体外活性 | NM107 reduces the number of viral plaques in BHK-21 cells infected with dengue type 2, reovirus type 1, West Nile, and yellow fever RNA viruses with EC50 values of 95, 26, 80, and 75 μM, respectively. NM107 inhibits hepatitis C virus (HCV) replication (EC50 = 2.2 μM in a replicon assay) and protects MDBK cells from infection with bovine virus diarrhea virus (BVDV; EC50 = 2.2 μM) and human corona virus (HCoV; EC50 = 90 μM). It also reduces infectious virus yield in BHK-21 cells infected with foot-and-mouth disease virus (FMDV; EC50 = 6.4 μM) and swine vesicular disease virus (SVDV; EC50 = 45.2 μM)[1]. |
体内活性 | Prolonged norovirus shedding may occur in certain patients, such as organ transplant recipients. Established a mouse model for persistent norovirus infection (using the mouse norovirus MNV.CR6 strain). The nucleoside viral polymerase inhibitor 2′-C-methylcytidine (2CMC), but not favipiravir (T-705), reduced viral shedding to undetectable levels. Viral rebound was observed after stopping treatment, which was again effectively controlled by treatment with 2CMC. No drug-resistant variants emerged[2]. |
动物实验 | For all experiments, age- and sex-matched mice 8 to 12 weeks of age were infected by oral gavage with 10^6 CCID50 (50% cell culture infective doses) of CR6. At 7 days postinfection (p.i.), mice were left untreated (n = 9) or were treated with 100 mg/kg daily of 2'-C-Methylcytidine(2CMC) subcutaneously for 5 (n = 4), 7 (n = 4), or 11 (n = 4) days. Two more rounds of a 14-day treatment (with an ~4-week interval in between) with 2CMC (n = 10) or favipiravir (200 mg/kg daily by oral gavage [n = 5]) were given. On each day after infection, the general condition and weight of treated and untreated mice were assessed, individual stool samples were collected (whenever possible during one daily period of observation), and levels of MNV RNA were quantified by reverse transcriptase quantitative PCR (RT-qPCR)[2]. |
别名 | NM-107, 2'-C-甲基胞嘧啶核苷, 2'-C-Methylcytidine |
分子量 | 257.24 |
分子式 | C10H15N3O5 |
CAS No. | 20724-73-6 |
Smiles | C[C@@]1(O)[C@H](O)[C@@H](CO)O[C@H]1n1ccc(N)nc1=O |
密度 | 1.72g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | H2O: 50 mg/mL (194.37 mM) | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容